Advertisement

Journal of Autism and Developmental Disorders

, Volume 37, Issue 10, pp 1934–1940 | Cite as

Hyperserotonemia in Adults with Autistic Disorder

  • Dubravka Hranilovic
  • Zorana Bujas-Petkovic
  • Renata Vragovic
  • Tomislav Vuk
  • Karlo Hock
  • Branimir Jernej
Original Paper

Abstract

Hyperserotonemia is the most consistent serotonin-related finding in autism. The basis of this phenomenon, and its relationship to the central serotonergic dysfunction remains unclear. Platelet serotonin level (PSL) in 53 autistic adults and 45 healthy controls was measured. Mean PSL in autistic group (75.7 ± 37.4 ng/μL) was significantly higher than the control sample (59.2 ± 16.2 ng/μL) due to a presence of hyperserotonemic subjects which comprised 32% of the patients. PSL of autistic subjects did not correlate with the severity of symptoms, as measured by total CARS score, or the degree of mental retardation. However, significant negative relationship was observed between PSL and speech development, indicating the relationship between the peripheral 5HT concentrations and verbal abilities in autistic subjects.

Keywords

Autism Hyperserotonemia Platelet serotonin level Speech development Verbal communication 

Notes

Acknowledgments

This study was supported by the Ministry of Science Education and Sports of the Republic of Croatia. The authors wish to thank Mrs. Drina Bagaric, a medical laboratory engineer, for her skillful, kind, and gentle approach to the patients during blood sampling, and to Mrs. Katarina Karlo, a senior technician, for her assistance in PSL measurements.

References

  1. Anderson, G. M. (1987). Monoamines in autism: An update of neurochemical research on a pervasive developmental disorder. Medical Biology, 65, 67–74.PubMedGoogle Scholar
  2. Campbell, M., Friedman, E., DeVito, E., Greenspan, L., & Collins, P. J. (1974). Blood serotonin in psychotic and brain damaged children. Journal of Autism and Childhood Schizophrenia, 4, 33–41.PubMedCrossRefGoogle Scholar
  3. Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.PubMedCrossRefGoogle Scholar
  4. Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., et al. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666–669.PubMedCrossRefGoogle Scholar
  5. Cook, E. H. Jr., Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., et al. (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sciences, 52, 2005–2015.PubMedCrossRefGoogle Scholar
  6. Cook, E. H. Jr., & Leventhal, B. L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348–354.PubMedCrossRefGoogle Scholar
  7. Cook, E. H. Jr., Leventhal, B. L., Heller, W., Metz, J., Wainwright, M., & Freedman, D. X. (1990). Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268–274.PubMedGoogle Scholar
  8. Coutinho, A. M., Oliveira, G., Morgadinho, T., Fesel, C., Macedo, T. R., Bento, C., et al. (2004). Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry, 9, 264–271.PubMedCrossRefGoogle Scholar
  9. Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., et al. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.PubMedCrossRefGoogle Scholar
  10. Croonenberghs, J., Verkerk, R., Scharpe, S., Deboutte, D., & Maes, M. (2005). Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences, 76, 2171–2183.PubMedCrossRefGoogle Scholar
  11. Cuccaro, M. L., Wright, H. H., Abramson, R. K., Marsteller, F. A., & Valentine, J. (1993). Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 94–101.PubMedGoogle Scholar
  12. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman S., & Iyengar, R. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582–589.PubMedCrossRefGoogle Scholar
  13. Janusonis, S. (2005). Serotonergic paradoxes of autism replicated in a simple mathematical model. Medical Hypotheses, 64, 742–750.PubMedCrossRefGoogle Scholar
  14. Jernej, B., Banovic, M., Cicin-Sain, L., Hranilovic, D., Balija, M., Oreskovic, D., & Folnegovic-Smalc, V. (2000). Physiological characteristics of platelet/circulatory serotonin: Study on a large human population. Psychiatry Research, 94, 153–162.PubMedCrossRefGoogle Scholar
  15. Jernej, B., Cicin-Sain, L., & Iskric, S. (1988). A simple and reliable method for monitoring platelet serotonin levels in rats. Life Sciences, 43, 1663–1670.PubMedCrossRefGoogle Scholar
  16. Jones, M. B., & Szatmari, P. (2002). A risk-factor model of epistatic interaction, focusing on autism. American Journal of Medical Genetics, 114, 558–565.PubMedCrossRefGoogle Scholar
  17. Kuperman, S., Beeghly, J., Burns, T., & Tsai, L. (1987). Association of serotonin concentration to behavior and IQ in autistic children. Journal of Autism and Developmental Disorders, 17, 133–140.PubMedCrossRefGoogle Scholar
  18. Limpert, E., Stahel, W. A., & Abbt, M. (2001). Log-normal ndistributions across the sciences: Keyes and clues. BioScience, 51, 341–352.CrossRefGoogle Scholar
  19. Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., et al. (2000). Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry, 33, 165–168.PubMedCrossRefGoogle Scholar
  20. McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776.PubMedCrossRefGoogle Scholar
  21. McDougle, C. J., Naylor, S. T., Cohen D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996a). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.Google Scholar
  22. McDougle, C .J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996b). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993–1000.Google Scholar
  23. Muhle, R., Trentacoste, S. V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 13, 472–486.CrossRefGoogle Scholar
  24. Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., & Minderaa, R. B. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry 43, 491–499.PubMedCrossRefGoogle Scholar
  25. Owley, T., Leventhal, B. L., & Cook, E. H. (2003). Childhood Disorders: The autism spectrum disorders. In A. Tasman, J. Kay, & J. A. Lieberman (Eds.), Psychiatry. 2nd ed., (pp. 757–770). Chichester: Wiley.Google Scholar
  26. Ritvo, E., Yuwiler, A., Geller, E., Plotkin, S., Mason, A., & Saeger, K. (1971). Maturational changes in blood serotonin levels and platelet counts. Biochemical Medicine 5, 90–96.PubMedCrossRefGoogle Scholar
  27. Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Autism and Developmental Disorders 10, 91–103.PubMedCrossRefGoogle Scholar
  28. Spivak, B., Golubchik, P., Mozes, T., Vered, Y., Nechmad, A., Weizman, A., & Strous, R. D. (2004). Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 50, 157–160.PubMedCrossRefGoogle Scholar
  29. Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Dubravka Hranilovic
    • 1
    • 2
  • Zorana Bujas-Petkovic
    • 3
  • Renata Vragovic
    • 4
  • Tomislav Vuk
    • 5
  • Karlo Hock
    • 6
  • Branimir Jernej
    • 2
  1. 1.Department of Animal Physiology, Faculty of ScienceUniversity of ZagrebZagrebCroatia
  2. 2.Department of Molecular BiologyRudjer Boskovic InstituteZagrebCroatia
  3. 3.Psychiatric Hospital for Children and YouthZagrebCroatia
  4. 4.Center for autism ZagrebZagrebCroatia
  5. 5.Croatian Institute of Transfusion MedicineZagrebCroatia
  6. 6.Department of Molecular MedicineRudjer Boskovic InstituteZagrebCroatia

Personalised recommendations